Single nucleotide polymorphism and its dynamics for pharmacogenomics

Interdisciplinary Sciences – Computational Life Sciences

Volumn 6, Issue 2, 2014, Pages 85-92

  Katara, Pramod ^a  

^a UNIVERSITY OF ALLAHABAD   (India)

Author keywords

Adverse Drug Response; Drug; Polymorphism; Variable Drug Response

Indexed keywords

GENOTYPE; HUMAN; HUMAN GENOME; PERSONALIZED MEDICINE; PHARMACOGENETICS; SINGLE NUCLEOTIDE POLYMORPHISM;

GENOME, HUMAN; GENOTYPE; HUMANS; INDIVIDUALIZED MEDICINE; PHARMACOGENETICS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84906768941     PISSN: 19132751     EISSN: 18671462     Source Type: Journal    
DOI: 10.1007/s12539-013-0007-x     Document Type: Review

References (47)

1. Appell ML, Berg J, Duley J, Evans WE, Kennedy MA, Lennard L, Marinaki T, McLeod HL, Relling MV, Schaeffeler E, Schwab M, Weinshilboum R, Yeoh AE, McDonagh EM, Hebert JM, Klein TE, Coulthard SA (2013) Nomenclature for alleles of the thiopurine methyltransferase gene. Pharmacogenet Genomics 23(4): 242-248.
2. Barnes MR (2006) Navigating the HapMap. Brief Bioinform 7: 211-224.
3. Biro JC, Biro JM (2004) A novel sequence similarity searching and visualization method based on overlapping translated nucleic acids: the blastNP. Med Hypotheses 62: 568-574.
4. Brandon MC, Lott MT, Nguyen KC, Spolim S, Navathe SB, Baldi P, Wallace DC (2005) MITOMAP: a human mitochondrial genome database-2004 update. Nucleic Acids Res 33: D611-D613.
5. Carlson CS, Eberle MA, Kruglyak L, Nickerson DA (2004) Mapping complex disease loci in whole-genome association studies. Nature 429: 446-452.
6. Chang HW, Chuang LY, Tsai MT, Yang CH (2012) The importance of integrating SNP and cheminformatics resources to pharmacogenomics. Curr Drug Metab 13: 991-999.
7. Danielson PB (2002) The cytochrome P450 superfamily: biochemistry, evolution and drug metabolism in humans. Curr Drug Metab 3(6): 561-597.
8. Frederic MY, Lalande M, Boileau C, Hamroun D, Claustres M, Beroud C, Collod-Beroud G (2009) UMD-predictor, a new prediction tool for nucleotide substitution pathogenicity - application to four genes: FBN1, FBN2, TGFBR1, and TGFBR2. Hum Mutat 30(6): 952-959.
9. Gattepaille LM, Jakobsson M, Blum MG (2013) Inferring population size changes with sequence and SNP data: lessons from human bottlenecks. Heredity (Edinb) 110(5): 409-419.
10. Hunt R, Sauna ZE, Ambudkar SV, Gottesman MM, Kimchi-Sarfaty C (2009) Silent (synonymous) SNPs: should we care about them? Methods Mol Biol 578: 23-39.
11. Huttunen KM, Mähönen N, Raunio H, Rautio J (2008) Cytochrome P450-activated prodrugs: targeted drug delivery. Cur MED Chem 15(23): 2346-2365.
12. International Hap Map Consortium, Frazer KA, Ballinger DG, Cox DR, Hinds DA, Stuve LL, Gibbs RA, Belmont JW, Boudreau A, Hardenbol P, Leal SM, Pasternak S, Wheeler DA, Willis TD, Yu F, Yang H, Zeng C, Gao Y, Hu H, Hu W, Li C, Lin W, Liu S, Pan H, Tang X, Wang J, Wang W, Yu J, Zhang B, Zhang Q, Zhao H, Zhao H, Zhou J, Gabriel SB, Barry R, Blumenstiel B, Camargo A, Defelice M, Faggart M, Goyette M, Gupta S, Moore J, Nguyen H, Onofrio RC, Parkin M, Roy J, Stahl E, Winchester E, Ziaugra L, Altshuler D, Shen Y, Yao Z, Huang W, Chu X, He Y, Jin L, Liu Y, Shen Y, Sun W, Wang H, Wang Y, Wang Y, Xiong X, Xu L, Waye MM, Tsui SK, Xue H, Wong JT, Galver LM, Fan JB, Gunderson K, Murray SS, Oliphant AR, Chee MS, Montpetit A, Chagnon F, Ferretti V, Leboeuf M, Olivier JF, Phillips MS, Roumy S, Sallée C, Verner A, Hudson TJ, Kwok PY, Cai D, Koboldt DC, Miller RD, Pawlikowska L, Taillon-Miller P, Xiao M, Tsui LC, Mak W, Song YQ, Tam PK, Nakamura Y, Kawaguchi T, Kitamoto T, Morizono T, Nagashima A, Ohnishi Y, Sekine A, Tanaka T, Tsunoda T, Deloukas P, Bird CP, Delgado M, Dermitzakis ET, Gwilliam R, Hunt S, Morrison J, Powell D, Stranger BE, Whittaker P, Bentley DR, Daly MJ, de Bakker PI, Barrett J, Chretien YR, Maller J, McCarroll S, Patterson N, Pe'er I, Price A, Purcell S, Richter DJ, Sabeti P, Saxena R, Schaffner SF, Sham PC, Varilly P, Altshuler D, Stein LD, Krishnan L, Smith AV, Tello-Ruiz MK, Thorisson GA, Chakravarti A, Chen PE, Cutler DJ, Kashuk CS, Lin S, Abecasis GR, Guan W, Li Y, Munro HM, Qin ZS, Thomas DJ, McVean G, Auton A, Bottolo L, Cardin N, Eyheramendy S, Freeman C, Marchini J, Myers S, Spencer C, Stephens M, Donnelly P, Cardon LR, Clarke G, Evans DM, Morris AP, Weir BS, Tsunoda T, Mullikin JC, Sherry ST, Feolo M, Skol A, Zhang H, Zeng C, Zhao H, Matsuda I, Fukushima Y, Macer DR, Suda E, Rotimi CN, Adebamowo CA, Ajayi I, Aniagwu T, Marshall PA, Nkwodimmah C, Royal CD, Leppert MF, Dixon M, Peiffer A, Qiu R, Kent A, Kato K, Niikawa N, Adewole IF, Knoppers BM, Foster MW, Clayton EW, Watkin J, Gibbs RA, Belmont JW, Muzny D, Nazareth L, Sodergren E, Weinstock GM, Wheeler DA, Yakub I, Gabriel SB, Onofrio RC, Richter DJ, Ziaugra L, Birren BW, Daly MJ, Altshuler D, Wilson RK, Fulton LL, Rogers J, Burton J, Carter NP, Clee CM, Griffiths M, Jones MC, McLay K, Plumb RW, Ross MT, Sims SK, Willey DL, Chen Z, Han H, Kang L, Godbout M, Wallenburg JC, L'Archevéque P, Bellemare G, Saeki K, Wang H, An D, Fu H, Li Q, Wang Z, Wang R, Holden AL, Brooks LD, McEwen JE, Guyer MS, Wang VO, Peterson JL, Shi M, Spiegel J, Sung LM, Zacharia LF, Collins FS, Kennedy K, Jamieson R, Stewart J (2007) A second generation human haplotype map of over 3. 1 million SNPs. Nature 449: 851-861.
13. Janjic V, Przulj N (2012) The Core Diseasome. Mol Biosyst 8: 2614-2625.
14. Katara P (2013) Role of bioinformatics and pharmacogenomics in drug discovery and development process. Netw Model Anal Health Inform Bioinforma DOI 10. 1007/s13721-013-0039-5.
15. Kirk BW, Feinsod M, Favis R, Kliman RM, Barany F (2002) Single nucleotide polymorphism seeking long term association with complex disease. Nucleic Acids Res 30(15): 3295-3311.
16. Klein K, Zanger UM (2013) Pharmacogenomics of Cytochrome P450 3A4: Recent Progress Toward the "Missing Heritability" Problem. Front Genet 4: 12.
17. Kumar A, Purohit R (2013) Cancer associated E17K mutation causes rapid conformational drift in AKT1 pleckstrin homology (PH) domain. PLoS One 8(5): e64364.
18. Kwok PY, Chen X (2003) Detection of single nucleotide polymorphisms. Curr Issues Mol Biol 5: 43-60.
19. Laing RE, Hess P, Shen Y, Wang J, Hu SX (2011) The role and impact of SNPs in pharmacogenomics and personalized medicine. Curr Drug Metab 12: 460-486.
20. Lennard L, Cartwright CS, Wade R, Richards SM, Vora A (2013) Thiopurine methyltransferase genotypephenotype discordance, and thiopurine active metabolite formation, in childhood acute lymphoblastic leukaemia. Br J Clin Pharmacol 76(1): 125.
21. Marsh S, Kwok P, McLeod HL (2002) SNP databases and pharmacogenetics: great start, but a long way to go. Hum Mutat 20: 174-179.
22. McCarthy JJ, Hilfiker R (2000) The use of singlenucleotide polymorphism maps in pharmacogenomics. Nat Biotechnol 18(5): 505-508.
23. McGraw J, Waller D (2012) Cytochrome P450 variations in different ethnic populations. Expert Opin Drug Metab Toxicol 8: 371-382.
24. Nebert DW, Wikvall K, Miller WL (2013) Human cytochromes P450 in health and disease. Philos Trans R Soc Lond B Biol Sci 368: 20120431.
25. Nelson DR (2013) A world of cytochrome P450s. Philos Trans R Soc Lond B Biol Sci 368: 20120430.
26. Ortiz de Montellano PR (2013) Cytochrome P450-activated prodrugs. Future Med Chem 5: 213-228.
27. Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R (2010) SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res 38: D237-D243.
28. Rajendran V, Purohit R, Sethumadhavan R (2012) In silico investigation of molecular mechanism of laminopathy caused by a point mutation (R482W) in lamin A/C protein. Amino Acids 43(2): 603-615.
29. Riva A, Kohane IS (2002) SNPper: retrieval and analysis of human SNPs. Bioinformatics 18: 1681-1685.
30. Roden DM, Wilke RA, Kroemer HK, Stein CM (2011) Pharmacogenomics: the genetics of variable drug responses. Circulation 123(15): 1661-1670.
31. Rozanov M, Plikat U, Chappey C, Kochergin A, Tatusova T (2004) A web-based genotyping resource for viral sequences. Nucleic Acids Res 32: W654-W659.
32. Rutherford K, Daggett V (2008) Four human thiopurine s-methyltransferase alleles severely affect protein structure and dynamics. J Mol Biol 379(4): 803-814.
33. Salavaggione OE, Wang L, Wiepert M, Yee VC, Weinshilboum RM (2005) Thiopurine S-methyltransferase pharmacogenetics: variant allele functional and comparative genomics. Pharmacogenet Genomics 15(11): 801-815.
34. Shastry BS (2009) SNPs: impact on gene function and phenotype. Methods Mol Biol 578: 3-22.
35. Sherry ST, Ward MH, Kholodov M, Baker J, Phan L, Smigielski EM, Sirotkin K (2001) dbSNP: the NCBI database of genetic variation. Nucleic Acids Res 29: 308-311.
36. Sim NL, Kumar P, Hu J, Henikoff S, Schneider G, Ng PC (2012) SIFT web server: predicting effects of amino acid substitutions on proteins. Nucleic Acids Res 40: W452-W457.
37. Smedley D, Haider S, Ballester B, Holland R, London D, Thorisson G, Kasprzyk A (2009) BioMart-biological queries made easy. BMC Genomics 10: 22.
38. Teo YY, Sim X, Ong RT, Tan AK, Chen J, Tantoso E, Small KS, Ku CS, Lee EJ, Seielstad M, Chia KS (2009) Singapore Genome Variation Project: a haplotype map of three Southeast Asian populations. Genome Res 19: 2154-2162.
39. Thorisson GA, Smith AV, Krishnan L, Stein LD (2005) The International HapMap Project Web site. Genome Res 15: 1592-1593.
40. Useche FJ, Gao G, Harafey M, Rafalski A (2001) Highthroughput identification, database storage and analysis of SNPs in EST sequences. Genome Inform 12: 194-203.
41. van Oeveren J, Janssen A (2009) Mining SNPs from DNA sequence data; computational approaches to SNP discovery and analysis. Methods Mol Biol 578: 73-91.
42. Wang J, Pang GS, Chong SS, Lee CG (2012) SNP web resources and their potential applications in personalized medicine. Curr Drug Metab 13: 978-990.
43. Weng L, Zhang L, Peng Y, Huang RS (2013) Pharmacogenetics and pharmacogenomics: a bridge to individualized cancer therapy. Pharmacogenomics 14(3): 315-324.
44. Whirl-Carrillo M, McDonagh EM, Hebert JM, Gong L, Sangkuhl K, Thorn CF, Altman RB, Klein TE (2012) Pharmacogenomics knowledge for personalized medicine. Clin Pharmacol Ther 92(4): 414-417.
45. Yang CH, Cheng YH, Chuang LY, Chang HW (2013) Drug-SNPing: an integrated drug-based, protein interaction-based tagSNP-based pharmacogenomics platform for SNP genotyping. Bioinformatics 29(6): 758-764.
46. Zanger UM, Schwab M (2013) Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther 138(1): 103-141.
47. Zou M, Baitei EY, Alzahrani AS, Parhar RS, Al-Mohanna FA, Meyer BF, Shi Y (2011) Mutation prediction by PolyPhen or functional assay, a detailed comparison of CYP27B1 missense mutations. Endocrine 40: 14-20.